Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 136 AL 150

Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study

Tai SY, Chen CH, Chien CY, Yang YH.

BMC Neurol. 2017 Feb 23;17(1):40. doi: 10.1186/s12883-017-0800-y.

Always in Tune: The Unforgettable Memory for Music in Alzheimer's Disease

Fornazzari L, Mansur A, Acuna KO, Schweizer TA, Fischer CE.

Can J Neurol Sci. 2017 Mar;44(2):209-211. doi: 10.1017/cjn.2016.436.

Special topic section on health economics and public policy of Alzheimer's disease

Jönsson L, Lin PJ, Khachaturian AS.

Alzheimers Dement. 2017 Mar;13(3):201-204. doi: 10.1016/j.jalz.2017.02.004. Epub 2017 Feb 21.

A Potential Role of Periodontal Inflammation in Alzheimer's Disease: A Review

Ganesh P, Karthikeyan R, Muthukumaraswamy A, Anand J.

Oral Health Prev Dent. 2017;15(1):7-12. doi: 10.3290/j.ohpd.a37708.

Physical Function Differences Between the Stages From Normal Cognition to Moderate Alzheimer Disease

Fujisawa C, Umegaki H, Okamoto K, Nakashima H, Kuzuya M, Toba K, Sakurai T.

J Am Med Dir Assoc. 2017 Apr 1;18(4):368.e9-368.e15. doi: 10.1016/j.jamda.2016.12.079. Epub 2017 Feb 22.

Editorial: Current and Emerging Therapeutics in AD

Sabbagh M, Decourt B.

Curr Alzheimer Res. 2017;14(4):354-355. doi: 10.2174/156720501404170217182758.

A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer's dementia supported by structure prediction

Park KW, An SS, Bagyinszky E, Kim S.

Clin Interv Aging. 2017 Feb 13;12:367-375. doi: 10.2147/CIA.S128884. eCollection 2017.

Lack of a Role for Alzheimer's Disease Pathology in Late-Life Depression, or Just No Relationship With Amyloid?

Taylor WD.

Am J Psychiatry. 2017 Mar 1;174(3):197-198. doi: 10.1176/appi.ajp.2016.16111317.

On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis

Area-Gomez E, Schon EA.

FASEB J. 2017 Mar;31(3):864-867. doi: 10.1096/fj.201601309.

Biophenols pharmacology against the amyloidogenic activity in Alzheimer's disease

Omar SH.

Biomed Pharmacother. 2017 May;89:396-413. doi: 10.1016/j.biopha.2017.02.051. Epub 2017 Feb 27.

Sleep and hippocampal neurogenesis: Implications for Alzheimer's disease

Kent BA, Mistlberger RE.

Front Neuroendocrinol. 2017 Apr;45:35-52. doi: 10.1016/j.yfrne.2017.02.004. Epub 2017 Feb 27.

Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!

Cardoso SM, Correia SC, Carvalho C, Moreira PI.

Handb Exp Pharmacol. 2017;240:281-308. doi: 10.1007/164_2017_3.

Alzheimer's disease pathology and the unfolded protein response: prospective pathways and therapeutic targets

Koss DJ, Platt B.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):161-178. doi: 10.1097/FBP.0000000000000299.

Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer's disease

Calhoun A, Ko J, Grossberg GT.

Expert Opin Emerg Drugs. 2017 Mar;22(1):101-105. doi: 10.1080/14728214.2017.1293651.

Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease

Reddy AP, Reddy PH.

Prog Mol Biol Transl Sci. 2017;146:173-201. doi: 10.1016/bs.pmbts.2016.12.010. Epub 2017 Feb 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias